What researchers published on IgA nephropathy
834 papers, newest first.
Showing 200 of 834
Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data. Reply.The New England journal of medicine
Not labelled yetIptacopan in IgA Nephropathy - Final 24-Month Data.The New England journal of medicine
Not labelled yetClinical significance of the systemic immune-inflammation index as a minimally invasive biomarker reflecting histological activity in IgA nephropathy.Renal failure
Not labelled yetCurrent status and optimization strategies for immunoglobulin a nephropathy management in the Western Region of Chongqing, China: A cross-sectional study.Medicine
Not labelled yetImpact of recurrent IgA nephropathy on long-term kidney transplant outcomes: a cohort comparison with autosomal dominant polycystic kidney disease.BMC nephrology
ReviewThe oral-kidney axis in IgA nephropathy: cnm-positive Streptococcus mutans as a microbial trigger.Clinical and experimental nephrology
Not labelled yetUp-regulation of CXCR3 on tonsillar T-cells in patients with IgA nephropathy.Clinical and experimental immunology
Not labelled yetPathogenic Gd-IgA1: Redefining the Role of Galactose-Deficient IgA1 in IgA Nephropathy.Journal of the American Society of Nephrology : JASN
Not labelled yetLongitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy: A real-world cohort study.Clinical nephrology
Not labelled yetReview of the 10-year kidney biopsy experience of the Szeged Nephrology and Hypertension Center: a comparison of pre-biopsy clinical and biopsy-proven histological diagnoses.Renal failure
ReviewIgA nephropathy: evolving treatment strategies.Jornal brasileiro de nefrologia
Case reportCombined Rituximab and Daratumumab Induces Remission in Refractory Post-Transplant Crescentic IgA Nephropathy.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Not labelled yetPerceptions and preferences of self-injectable therapies among adults living with immunoglobulin A nephropathy in the United States: a mixed-methods study.Current medical research and opinion
Not labelled yetSparsentan as First-Line Treatment in IgAN From SPARTAN.Kidney international reports
Not labelled yetRituximab in IgA Nephropathy: The RITA Multicenter Randomized Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation
Case reportPulmonary-Cardiac Involvement in a Patient with IgA Vasculitis.Methodist DeBakey cardiovascular journal
PreprintMucosal Inflammation as a Driver of Gd-IgA1 Production in IgA Nephropathy: Mechanistic Support for Targeted Therapies.bioRxiv : the preprint server for biology
Not labelled yetTranscriptomic Identification of Candidate Biomarkers Associated With Vascular Calcification-Related Signaling Pathways in Immunoglobulin A Nephropathy.International journal of genomics
Not labelled yetSibeprenlimab in IgA nephropathy: does the fairy tale continue in phase 3?Annals of translational medicine
Case reportIgA nephropathy in a patient with 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 p. Y329fs mutation: a case report and review.BMC pediatrics
Not labelled yetIntegrated Transcriptomic Analysis and Experimental Validation Identify ATF3 as a Mesangial Cell-Associated Candidate Regulator in IgA Nephropathy.Journal of inflammation research
Not labelled yetPrognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy.Renal failure
Not labelled yetMulti-Omics Analysis Uncovers a Link Between Dysregulated Steroid Hormone Biosynthesis and Pediatric IgA Vasculitis Nephritis.Frontiers in bioscience (Landmark edition)
Not labelled yetAutomatic Ultrasound Habitat Radiomics for Differentiating Henoch-Schonlein Purpura Nephritis from IgA Nephropathy in Children: A Multicenter Study.Academic radiology
Not labelled yetTargeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.Drug design, development and therapy
Not labelled yetAssociation of tonsillar Pseudomonas identified by 16S rRNA sequencing with clinical remission after tonsillectomy in IgA nephropathy: a machine learning approach.Clinical and experimental nephrology
Not labelled yetWhen red eyes signal glomerular disease: IgA nephropathy presenting as recurrent episcleritis and scleritis.Tropical doctor
Systematic reviewCrystalline κ-light-chain proximal tubulopathy in Waldenström macroglobulinemia with an IgA nephropathy pattern: a case report and systematic review.Frontiers in immunology
In plain wordsRead moreRead the paper on PubMedNot labelled yetLessons from IgA nephropathy: reevaluating the prognosis and management of class I and class II lupus nephritis.Renal failure
ReviewTreatment and practical considerations of IgA nephropathy.Frontiers in medicine
Not labelled yetPrognostic value of the neutrophil percentage-to-albumin ratio in patients with IgA nephropathy.BMC nephrology
Not labelled yetAssociation of the Red Blood Cell Distribution Width-to-Albumin Ratio with Renal Outcomes in Chinese Patients with IgA Nephropathy.Journal of clinical medicine
Not labelled yetDU-KAN: A Dual-Domain Enhanced Deep-Learning Framework for Digital Pathology-Based Oxford MEST-C Assessment in Pediatric IgA Nephropathy.Bioengineering (Basel, Switzerland)
ReviewChallenges in access to novel IgA nephropathy therapeutics in South Asia.The Lancet regional health. Southeast Asia
Not labelled yetSuccessful Tocilizumab Monotherapy for Steroid-Dependent TAFRO Syndrome with IgA Nephropathy.Turkish journal of haematology : official journal of Turkish Society of Haematology
Case reportPostpartum Triple Allograft Injury with Atypical Hemolytic Uremic Syndrome, Recurrent IgA Nephropathy, and Antibody-Mediated Rejection in a Kidney Retransplant Recipient: A Case Report.Journal of clinical medicine
Not labelled yetPregnancy Outcomes and Long-Term Kidney Function in Women with Primary Glomerulonephritis.Journal of nephrology
Not labelled yetCombined and simultaneous use of Nefecon and irbesartan in treatment-naïve primary IgA nephropathy: A retrospective study.Medicine
Not labelled yetHow I Do It: Recurrent IgA Nephropathy After Transplant-Integrating Emerging Therapies Into Practice.Transplantation
ReviewIgA nephropathy: evolving pathogenic concepts and emerging targeted therapies.Human immunology
Not labelled yetClinical characteristics and prognosis of IgA nephropathy with predominant light chain deposition.Renal failure
ReviewPrimary Mesangial Proliferative Glomerulonephritis: The Forgotten Glomerulopathy.Antibodies (Basel, Switzerland)
ReviewIgA nephropathy: gut microbiome insights and unmet needs in pediatrics.Pediatric nephrology (Berlin, Germany)
ReviewB-cell modulators in immunoglobulin A nephropathy.Frontiers in immunology
Not labelled yetLeast but not last: Durable C5 silencing for IgA nephropathy.Molecular therapy : the journal of the American Society of Gene Therapy
Not labelled yetPeritoneal M2 macrophage-derived extracellular vesicles as a nanotherapeutic for immune-oxidative microenvironment reprogramming in IgA nephropathy.Journal of materials chemistry. B
Not labelled yetRavulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.The New England journal of medicine
Not labelled yetLong-term efficacy and safety for the complement factor B inhibitor iptacopan in IgA nephropathy.Kidney international
Not labelled yetOutcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic Kidney Disease and Other Glomerular Diseases.American journal of kidney diseases : the official journal of the National Kidney Foundation
Not labelled yetAtacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis.The New England journal of medicine
Not labelled yetKidney biopsy in the diagnosis of immunoglobulin A nephropathy.Frontiers in medicine
Not labelled yetUrinary Biomarker Analysis of the SANCTUARY Trial: Insights into IgA Nephropathy Pathophysiology and Ravulizumab Mechanism of Action.Clinical journal of the American Society of Nephrology : CJASN
Randomised trialInterim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy.The New England journal of medicine
In plain wordsRead moreRead the paper on PubMedNot labelled yetSibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis.The New England journal of medicine
Not labelled yetCharacterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry.Kidney international
Not labelled yetExosomal C3a initiates the NF-κB-dependent inflammatory axis in IgA nephropathy: a three-phase pilot study integrating clinical, in vivo, and in vitro evidence.Clinical and experimental nephrology
Not labelled yetGlomerulonephritis before and after BNT162b2 mRNA vaccine rollout: biopsy-based trends, histopathological spectrum, and temporal associations.International urology and nephrology
Not labelled yetSingle-cell transcriptomic analysis of the terminal ileum identifies BCMA as a therapeutic target in IgA nephropathy.hLife
Not labelled yet[Preliminary evaluation of the efficacy and safety of telitacicept in children with IgA nephropathy].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Not labelled yetCorrection: Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.Frontiers in pharmacology
Not labelled yetCorticosteroids, serum proteins, and the next phase of precision medicine in IgA nephropathy.Clinical kidney journal
Not labelled yetIntegrating multiple omics approaches to identify AIF1 as a protective factor in IgA nephropathy.Journal of translational autoimmunity
Not labelled yetEfficacy and safety of low-dose telitacicept in IgA nephropathy: a real-world study.Clinical kidney journal
Review[IgA Nephropathy Update 2025/2026].Deutsche medizinische Wochenschrift (1946)
Not labelled yetSafety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy.Clinical and experimental nephrology
ReviewGd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~.Frontiers in nephrology
Systematic reviewMapping the complement-targeted landscape in igA nephropathy: a systematic review with structured descriptive synthesis.Frontiers in medicine
In plain wordsRead moreRead the paper on PubMedNot labelled yetGlomerular Properdin Deposition Suggests a Favorable Therapeutic Response to Tonsillectomy and Steroid Pulse Therapy in IgA Nephropathy.Cureus
Not labelled yetFrom therapeutic lag to clinical trials: the changing landscape of pediatric IgA nephropathy.Pediatric nephrology (Berlin, Germany)
ReviewFrom Susceptibility Loci to Therapeutic Targets: The Genetic Architecture of IgA Nephropathy.International journal of molecular sciences
Not labelled yetHigh Prevalence of Oxford MEST-C Lesions in Immunoglobulin A Nephropathy of Kidney Allografts: A Single-Center Study from Viet Nam.Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Not labelled yetReal-World Effectiveness of Targeted-Release Budesonide in IgA Nephropathy with Near-Universal SGLT2 Inhibitor Use.American journal of nephrology
Not labelled yetMicroangiopathic lesions associated with poor immunosuppressive therapy response in IgA nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Not labelled yetMetabolic profiles of IgA nephropathy, membranous nephropathy, and diabetic nephropathy.Archives of medical science : AMS
ReviewMonoclonal antibodies associated IgA nephropathy or other nephropathies.Frontiers in pharmacology
Not labelled yetPrognostic utility of Oxford MEST-C classification for allograft failure in transplant IgA nephropathy: A systematic review and meta-analysis.Journal of nephrology
Case reportTriple Renal Pathology in a Patient With Myeloperoxidase-Associated Vasculitis, Diabetic Nephropathy, and Immunoglobulin A Nephropathy: A Case Report.Cureus
ReviewPotential Roles of Escherichia coli in IgA Nephropathy: Evidence, Mechanistic Hypotheses and Microbiota-Targeted Strategies.Microbial biotechnology
Not labelled yetAssociation of Hemoglobin Levels with Progression to End-Stage Kidney Disease in IgA Nephropathy: A Sex-Specific Analysis.American journal of nephrology
Not labelled yetDevelopment and validation of a predictive model for rapid renal function decline in early IgA nephropathy: a multicenter retrospective study.Frontiers in medicine
ReviewComplement biomarkers in IgA nephropathy: current insights and clinical relevance.Frontiers in nephrology
Not labelled yetShort-term changes in clinical parameters associated with telitacicept in pediatric IgA nephropathy: a single-center self-controlled observational study.Frontiers in pediatrics
Not labelled yetTargeted-Release Formulation Budesonide (Nefecon) for the Treatment of IgA Nephropathy in Three Adolescents.Kidney360
Not labelled yetClinical and pathological factors associated with eGFR slope in IgA nephropathy: a single-center retrospective cohort study.Renal failure
ReviewMesenchymal stem cells: a potential therapeutic strategy for IgA nephropathy.Frontiers in pharmacology
ReviewTargeting the B-Cell Activating Factor and a Proliferation-Inducing Ligand Pathway in IgAN: From Disease Pathogenesis to Clinical Trial Evidence.Kidney international reports
ReviewIntegrated Traditional Chinese and Western Medicine for Immunoglobulin A Nephropathy: Recent Advances and Future Directions.Seminars in nephrology
Not labelled yetIntegrated analysis identifies dysregulated secretory proteins and crotonylation profiles associated with immune regulation in IgA nephropathy.Journal of proteomics
Not labelled yetThe lactate dehydrogenase-to-albumin ratio is independently associated with moderate-to-severe tubulointerstitial fibrosis in patients with IgA nephropathy.Frontiers in nephrology
Not labelled yetSystematic Review of Persistent Microscopic Hematuria and Kidney Outcomes in IgAN.Kidney international reports
Meta-analysisArtificial intelligence-powered renal pathology for glomerular disease classification: a systematic review and meta-analysis.Renal failure
In plain wordsRead moreRead the paper on PubMedNot labelled yetCross-phenotype integration of eQTL-based Mendelian randomization and transcriptomics prioritizes BMP2K in IgA vasculitis with nephritis.Frontiers in immunology
Not labelled yetVaccination timing and humoral suppression with telitacicept in IgA nephropathy.International urology and nephrology
Not labelled yetLong-term kidney outcomes associated with telitacicept in patients with IgA nephropathy: a 24-month retrospective comparative cohort study.Clinical kidney journal
Case reportCase Report: Concurrent Fabry disease, IgA nephropathy and undifferentiated connective tissue disease in a female with normal enzyme activity.Frontiers in immunology
ReviewMicroplastics and IgA nephropathy: a novel environmental hypothesis of immune dysregulation.Renal failure
Not labelled yetPrognostic value of serum total bilirubin-lipid ratios in patients with IgA nephropathy.Frontiers in endocrinology
Not labelled yetFinerenone in IgA nephropathy: A Systematic Review of Real-world Studies.Journal of nephrology
Not labelled yetHigh complement activation index predicts renal progression in crescentic IgA nephropathy.Frontiers in immunology
Not labelled yetComparative Analysis of Clinical and Pathological Traits in IgA Nephropathy Patients with Nephrotic Syndrome or Nephrotic Range Proteinuria.Kidney & blood pressure research
Meta-analysisTargeted-release Budesonide (Nefecon) versus systemic glucocorticoids for IgA nephropathy: a placebo-anchored indirect treatment comparison of randomized controlled trials.BMC nephrology
In plain wordsRead moreRead the paper on PubMedReview[Summary IgA nephropathy, or Berger's disease].La Revue du praticien
Not labelled yetThe prevalence of IgA nephropathy in Japan: results from a nationwide survey.Clinical and experimental nephrology
Not labelled yetSmoking exposure and long-term progression of IgA nephropathy: a retrospective cohort study of 9,560 patients.Renal failure
Not labelled yetComparison of efficacy and safety of systemic glucocorticoids and Nefecon in IgA nephropathy patients: a real-world retrospective cohort study.Frontiers in immunology
Not labelled yetPodocyte Vps34 deficiency drives early-onset glomerulopathy and mesangial IgA-dominant immune-complex deposition: a novel mouse model linking vesicular trafficking to glomerular immune dysregulation.Frontiers in immunology
Not labelled yetIgA Nephropathy at a Therapeutic Inflection: From Supportive Care to Pathway-Specific Therapy.International journal of rheumatic diseases
Case reportCase Report: Advanced IgA nephropathy with psoriasis and a complex clinicopathologic course.Frontiers in nephrology
Not labelled yetCorrection: A comparative study on the clinicopathological features and short-term prognosis of IgA-dominant infection-related glomerulonephritis and IgA nephropathy.BMC nephrology
Not labelled yetPredictors of response and long-term tolerability of sparsentan in a real-world IgA nephropathy cohort.Clinical kidney journal
Not labelled yetAnalytical validation of an ELISA-based test kit for polymeric IgA immune complexes in IgA nephropathy.Clinical nephrology
Case reportImmunoglobulin A-dominant crescentic glomerulonephritis in a teenage refugee with active methicillin-resistant Staphylococcus aureus urinary infection: a diagnostic and therapeutic dilemma.BMJ case reports
Not labelled yetPatient characteristics, treatment patterns and clinical outcomes of immunoglobulin a nephropathy (IgAN) in China: a retrospective cohort study.BMJ open
ReviewLayered immune biomarker monitoring in IgA nephropathy: from mucosal IgA dysregulation to precision therapeutic response assessment.Frontiers in medicine
Not labelled yetHigh levels of galactose-deficient IgA1 are insufficient to induce IgA nephropathy: insight from a C1GALT1C1 variant.Kidney international
Not labelled yetCorrigendum to "Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis." Kidney International 2025;108:1158-1169.Kidney international
Not labelled yetClinical remission trajectories and histopathological associations in patients with IgA nephropathy treated with targeted-release budesonide: a real-world cohort study.Frontiers in immunology
Not labelled yetTonsillar Tfh cells contribute to the pathogenesis of IgA nephropathy in collaboration with memory B cells.Frontiers in immunology
Not labelled yet[Pathological characteristics, therapeutic strategies, and prognostic assessment in children with crescentic IgA vasculitis with nephritis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Not labelled yetTwelve-month real-world outcomes of sparsentan in a multicenter Spanish IgA nephropathy cohort.Clinical kidney journal
Not labelled yetThe Three Faces of IgA Nephropathy: Clinicopathological Heterogeneity and Urinary Albumin-to-Protein Ratio in a Case Series.Journal of clinical medicine
Not labelled yetHaematuria-Guided Therapy in Immunoglobulin A Nephropathy: From Biological Activity to Treatment Selection.Nephrology (Carlton, Vic.)
Not labelled yetA shared immunological context underlying IgA nephropathy.CEN case reports
Not labelled yetBiopsy-proven dengue virus-associated IgA nephropathy and interstitial nephritis with viral RNA detected in kidney tissue.Travel medicine and infectious disease
Not labelled yetSparsentan - SGLT2 inhibitor combination therapy in trials of IgA nephropathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Not labelled yetCBL0137 inhibits TFR2-mediated IgA1 deposition in IgA nephropathy.International immunopharmacology
ReviewComplement in Kidney Disease: Core Curriculum 2026.American journal of kidney diseases : the official journal of the National Kidney Foundation
ReviewAtacicept: First Approval.Drugs
Not labelled yetClinical characteristics and prognosis of IgA nephropathy and comorbid diabetic kidney disease.Annals of medicine
Not labelled yetThe Association Between IgA Nephropathy and Uveitis Using Clinical Setting Data.Ocular immunology and inflammation
Not labelled yetEffectiveness and Safety of Nefecon in Primary IgA Nephropathy Across Different Baseline Proteinuria Levels: A Real-World Study.Advances in therapy
ReviewAtacicept in IgA nephropathy.Expert review of clinical immunology
Not labelled yetClinical Significance of Increased Degree of Hematuria in Patients affected by IgA Nephropathy.Journal of nephrology
Not labelled yetNon-invasive risk stratification of immunoglobulin A nephropathy and crescent formation using contrast-enhanced ultrasound combined with serological markers.Quantitative imaging in medicine and surgery
Not labelled yetSarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Not labelled yetRituximab-Based Therapy in IgA Nephropathy With Crescents: A Comparative Study.Clinical therapeutics
Meta-analysisCrescents in native kidney biopsies from patients with IgA nephropathy and the risk of recurrence after kidney transplantation: a retrospective cohort study, systematic literature review and meta-analysis of observational studies.Journal of nephrology
In plain wordsRead moreRead the paper on PubMedNot labelled yetEfficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.Frontiers in pharmacology
Not labelled yetManagement strategies for post-transplant IgA nephropathy in kidney transplant recipients: a scoping review.BMC nephrology
Not labelled yetKidney biopsy in patients with small kidneys: diagnostic yield and treatment modification in a retrospective cohort study.Renal failure
Not labelled yetDecoding vascular calcification-neutrophil signature in pathogenesis of chronic IgA nephropathy: evidence from artificial intelligence-driven multi-omics and in vitro validation.Frontiers in physiology
Not labelled yetTelitacicept for IgA Nephropathy.The New England journal of medicine
Not labelled yetTelitacicept for IgA Nephropathy.The New England journal of medicine
Not labelled yetTelitacicept for IgA Nephropathy. Reply.The New England journal of medicine
Observational studyReal-world multicenter evidence on Nefecon for attenuating proteinuria and kidney function decline in IgA nephropathy.Frontiers in immunology
Not labelled yetAssociation of Renal CD68+ Cell Infiltration with Oxford Classification in IgA Nephropathy.Iranian journal of kidney diseases
Not labelled yetCorrigendum to "Neutrophil extracellular traps promote glomerular endothelial injury in IgA nephropathy via the cGAS-STING pathway" [Biochem. Pharmacol. 253 (2026) 118354].Biochemical pharmacology
Not labelled yetLarge language models decode narrative pathology reports to define clinically relevant subtypes in IgA nephropathy.Nature communications
Not labelled yetEfficacy and safety of henagliflozin in IgA nephropathy: A real-world observational study from China.Clinical nephrology
Not labelled yetClinical Predictors of Non-Diabetic Glomerular Disease in Type 2 Diabetic Patients With Nephrotic-Range Proteinuria.Nephrology (Carlton, Vic.)
ReviewShort interference RNAs in glomerulonephritis: A mini review.BioImpacts : BI
Not labelled yetMechanisms of Liancao Xueniao Capsules in Treating Hematuria Associated with IgA Nephropathy: Network Pharmacology and Experimental Validation.Journal of visualized experiments : JoVE
Not labelled yetDissociated FoxP3 Up-regulation With Functional Surface Marker Loss Defines a Convergent Treg Paradox Across Immunological Archetypes of IgA Nephropathy and IgA Vasculitis.In vivo (Athens, Greece)
Not labelled yetIncorporating Pathomics Into IgAN Risk Prediction.Kidney international reports
Not labelled yetPractice Variation in IgA Nephropathy: When the Field Evolves Faster Than Consensus.Kidney360
Systematic reviewImpact of hematuria on long term kidney outcomes in adults with immunoglobulin A nephropathy: a systematic literature review and meta-analysis.Frontiers in nephrology
In plain wordsRead moreRead the paper on PubMedNot labelled yetAssociation Between Cardiac and Renal Biomarkers in IgA Nephropathy: Insights into Cardiorenal Interaction: A Cross-Sectional Study.Biomedicines
ReviewRole of Omega-3 Fatty Acids in IgA Nephropathy: An Updated Review of Mechanisms and Evidence.Journal of clinical medicine
ReviewEndothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.Journal of clinical hypertension (Greenwich, Conn.)
Not labelled yetA comparative study on the clinicopathological features and short-term prognosis of IgA-dominant infection-related glomerulonephritis and IgA nephropathy.BMC nephrology
Not labelled yetOutcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy.Kidney international
Not labelled yetDevelopment and validation of a routine urinalysis-based risk stratification model for IgA nephropathy in a multicenter real-world hospital population.Frontiers in nephrology
Not labelled yetHuangkui Capsule Effects in IgAN Through TLR4-Mediated Inflammatory Signaling.Journal of visualized experiments : JoVE
Not labelled yetReal-World Comparative Evidence for Telitacicept, Glucocorticoids, and Nefecon in IgA Nephropathy: Clinical Value and Interpretive Considerations [Letter].Drug design, development and therapy
ReviewGut-kidney axis in IgA nephropathy: mechanisms linking microbiota dysbiosis to immune dysregulation, Gd-IgA1 generation, and renal injury.Frontiers in immunology
Not labelled yetEfficacy and safety of finerenone in adults with IgA nephropathy: a 12-month real-world study.Renal failure
Not labelled yetWhat constitutes disease modification in IgA nephropathy?Clinical kidney journal
Not labelled yetEfficacy and safety of sibeprenlimab in IgA nephropathy: interim analysis of the China cohort in the phase 3 VISIONARY trial.Clinical kidney journal
Not labelled yetIdentification of key genes related to arginine metabolism in immunoglobulin A nephropathy through the combination of scRNA-seq and bulk RNA-seq data.Frontiers in immunology
Case reportConcurrent Anti-glomerular Basement Membrane (Anti-GBM) Disease and Immunoglobulin A Nephropathy (IgAN) Presenting With Severe Pulmonary-Renal Syndrome: A Case Report.Cureus
Not labelled yetTargeted release of budesonide modulates key gut microbial abnormalities in immunoglobulin A nephropathy.Frontiers in immunology
Not labelled yetA multi-center cohort study evaluated hemoglobinuria as a marker of inflammation in IgA nephropathy.Kidney international
Not labelled yetPotential diagnostic role of urinary exosomal microRNAs in immunoglobulin A nephropathy: A case-control study.World journal of nephrology
Not labelled yetA self-powered sensor with cascade signal amplification strategy based on CuS@Au heterojunctions/Ti3C2 MXene for detection of IgAN urinary miRNA-23b-3p.Talanta
Systematic reviewTelitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies.Frontiers in medicine
In plain wordsRead moreRead the paper on PubMedNot labelled yetShared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis.Frontiers in immunology
Not labelled yetClinical application of deep learning-based measurement of glomerular morphometry in IgAN.Frontiers in immunology
ReviewBreaking tolerance in the glomerulus: complement as a driver and therapeutic target in IgA nephropathy.Frontiers in medicine
Not labelled yetMonotypic IgA nephropathy: A large health system experience.Clinical nephrology
Not labelled yetAssociation of elevated homocysteine levels with renal pathology and function in patients with IgA nephropathy: a single-center retrospective study.Annals of medicine
Observational studyFinerenone for IgA Nephropathy After Renin-Angiotensin System Inhibitors Discontinuation: A Multicentre Retrospective Cohort Study.Diabetes, obesity & metabolism
Case reportSimultaneous Appearance of Immunoglobulin A Nephropathy and Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report.Case reports in nephrology and dialysis
Not labelled yetPreservation of Humoral Immunity and Response to Vaccination in Patients With IgAN Treated With Felzartamab.Kidney international reports
Observational studyAn observational study of patients receiving delayed-release budesonide (Nefecon) for immunoglobulin A nephropathy in the United States: A case series of Asian-American patients.Clinical nephrology
Not labelled yetA complement C5-targeted GalNAc-conjugated siRNA with sustained efficacy in a non-human primate model of IgA nephropathy.Molecular therapy : the journal of the American Society of Gene Therapy
Not labelled yetTargeted-release budesonide versus systemic corticosteroids in IgA nephropathy: a real-world comparative study.Frontiers in immunology
ReviewGut microbiota dysbiosis and immune responses: insights from IgA nephropathy and inflammatory bowel disease.Frontiers in immunology
Not labelled yetNeutrophil extracellular traps promote glomerular endothelial injury in IgA nephropathy via the cGAS-STING pathway.Biochemical pharmacology
ReviewPlasma Proteomics in IgA Nephropathy: From Circulating Biomarkers to Molecular Endotypes.Cells
Systematic reviewEfficacy and safety of BAFF/APRIL-pathway inhibitors versus placebo in adults with IgA nephropathy: a systematic review with pairwise and network meta-analysis.BMC nephrology
In plain wordsRead moreRead the paper on PubMedNot labelled yetAssociation between hematuria remission at 6 months and subsequent kidney outcomes in IgA nephropathy.Journal of nephrology
Meta-analysisThe Impact of Renin-Angiotensin-Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials.Clinical journal of the American Society of Nephrology : CJASN
In plain wordsRead moreRead the paper on PubMedSystematic reviewMechanisms and management of IgA nephropathy progression to end-stage renal disease: From the "four-hit" theory to precision medicine.Clinical nephrology
In plain wordsRead moreRead the paper on PubMedCase reportDiffering effects of Nefecon and Sparsentan in a patient with recurrent IgA nephropathy post-kidney transplantation.Clinical kidney journal
Systematic reviewDiagnostic value of urinary exosomes in patients with IgA nephropathy and diabetic kidney disease: a systematic review and meta-analysis.Frontiers in medicine
In plain wordsRead moreRead the paper on PubMedCase reportHow Late Is Too Late? Successful Use of Targeted-Release Budesonide in IgA Nephropathy with Estimated Glomerular Filtration Rate <30 mL/min/1.73 m2.Glomerular diseases
ReviewThe outcome of IgAN: a time of reflection in the perspective of new opportunities.Journal of nephrology
Not labelled yetHistopathologic and clinical spectrum of IgA nephropathy coexisting with other glomerulopathies; addressing the diagnostic challenges. Experience from a tertiary care center.Journal of nephrology